Drug Combination Details
| General Information of the Combination (ID: C55168) | |||||
|---|---|---|---|---|---|
| Name | Olanzapine NP Info | + | Fluoxetine Drug Info | ||
| Structure |
|
+ |
|
||
| Disease |
Depression
[ICD-11: 6A70-6A71]
|
Phase 3 | [1] | ||
|
Bipolar disorder
[ICD-11: 6A60]
|
Investigative | [2] | |||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [2] | |||||
| In-vivo Model | Clinical Trial | |||||
| Experimental
Result(s) |
Olanzapine/fluoxetine combination demonstrated rapid onset of antidepressant effect (within 7 days) compared to placebo that was sustained over 8 weeks of treatment in a sample of BD patients. | |||||